🇺🇸

M&A Activity

· daily

US Merger & Acquisition SEC Filings — August 11, 2026

The August 11, 2026 M&A digest reveals a bifurcated market: high-conviction, transformative mergers (Katapult's $4B+ revenue combination) and strategic divestitures (Duos Technologies, Bluerock Homes) are contrasted by early-stage SPAC activity (ARC Group's $105M IPO) and low-materiality corporate actions (East West Ave unit separation). Period-over-period data from the enriched filings shows a clear trend of companies shedding non-core assets to refocus on higher-growth verticals, with Duos and Bluerock both executing portfolio rationalizations. Insider activity is a critical signal—the Duos related-party sale to an interim CFO's entity raises governance flags, while the Katapult merger's 80% dilution to existing holders signals a severe value transfer. No forward-looking guidance was provided in any filing, but the scheduled events (e.g., Katapult's Q3 2026 earnings reflecting the merger) create a catalyst calendar. Capital allocation patterns are mixed: Bluerock is monetizing assets for cash, while ARC Group is deploying IPO proceeds into a trust for future M&A. The overarching theme is capital reallocation—companies are actively reshaping their portfolios, creating both risks (dilution, related-party conflicts) and opportunities (pure-play exposure, post-merger synergies).

6 high priority 6 total filings
· daily

US Merger & Acquisition SEC Filings — August 10, 2026

The August 10, 2026 M&A filing batch reveals a bifurcated SPAC market: while new IPOs (Pinnacle, East West Ave) continue to raise capital at $10/unit, the high-profile Yorkville-Crypto.com-TMTG deal collapsed, signaling waning SPAC appetite for complex transactions. Strategic acquisitions dominate, led by Amneal's transformative Kashiv BioSciences deal (biosimilars), Onto Innovation's $720M minority stake in Rigaku (semiconductor X-ray), and Ondas' Cyberhawk acquisition (drone inspection). Notable trends include a shift toward minority stakes and asset purchases with earn-outs (Byrna), reflecting disciplined capital deployment. Insider activity is limited, but sponsor ownership in East West Ave (15.12%) signals alignment. Forward-looking catalysts include Amneal's biosimilar launch cadence and Pinnacle's target search. Risks center on dilution (Ondas), deal termination fallout (Yorkville), and SPAC execution uncertainty (Dune, Quetta).

11 high priority 11 total filings
· daily

US Merger & Acquisition SEC Filings — August 07, 2026

The August 7, 2026 filings reveal a dynamic M&A landscape with significant strategic divestitures and acquisitions, particularly in the food service and energy sectors. Yum! Brands' $2.7 billion Pizza Hut divestiture (including the $1.2 billion sale to Yum China) is a landmark deal, with Yum China expecting mid-single-digit EPS accretion by 2027-2028 and margin expansion from eliminating the 3% license fee. Plains All American's $1.6 billion Canadian NGL sale to Keyera Corp. drove a 10% YoY Adjusted EBITDA increase and a leverage reduction to 3.3x, while raising organic growth capital guidance. The SPAC sector shows mixed signals: Mercator Acquisition Corp. completed a $172.5 million IPO but faces going concern issues, while Kensington and Silicon Valley Acquisition Corp. advance their business combinations. USA Rare Earth's acquisition of Texas Mineral Resources consolidates the rare earth sector. Insider activity is limited, but the resignation of two executives at Constellation Acquisition Corp I warrants attention. Overall, the period is marked by strategic portfolio reshaping, with companies using divestiture proceeds for debt reduction and growth investments.

11 high priority 11 total filings
· daily

US Merger & Acquisition SEC Filings — August 06, 2026

The August 6, 2026, M&A filings reveal a market bifurcated between high-conviction, well-financed deals (e.g., Liberty Global's €1B VodafoneZiggo buyout, Ensysce's $77M biotech acquisition) and opaque, high-risk SPAC combinations (Bleichroeder/Pasqal, Columbus/WISeSat) where shareholder value is uncertain. A clear trend of balance sheet deleveraging emerges, with Hydrofarm and BlackRock TCP Capital using asset sales to reduce debt by $591.6M and $16M, respectively, while Ashford Hospitality Trust's hotel sale highlights ongoing distress in commercial real estate. Insider activity is notably absent from most filings, but the presence of PIPE financing with price protection (Columbus/WISeSat) and milestone-based funding (Ensysce) suggests sophisticated capital structures designed to mitigate downside risk. The most actionable intelligence centers on the Ensysce/Cy Biopharma merger, which combines a deep-value stock price ($0.32/share) with a fully-funded pipeline catalyst, and the Liberty Global spin-off, which offers a unique tax-efficient return of capital. Conversely, the Bleichroeder/Pasqal deal presents significant governance and regulatory risks for retail investors, while the ACRES Commercial Realty filing signals potential distress in the commercial real estate sector.

15 high priority 15 total filings
· daily

US Merger & Acquisition SEC Filings — August 05, 2026

The August 5, 2026 filings reveal a highly active M&A landscape dominated by SPAC activity and strategic asset transactions. Key themes include a wave of SPAC IPOs (East West Ave, BOA Acquisition Corp II) raising $225M combined, and de-SPAC progress with McKinley Acquisition Corp announcing a $638M merger with Space-Eyes. Notable strategic M&A includes CoreCivic's $734M sale of two detention facilities to the DHS, and Palomino Laboratories' acquisition of Vega Links to expand into AI interconnects. Eton Pharmaceuticals licensed a promising late-stage dermatology product, while Medalist Diversified REIT executed a portfolio transformation through $76.6M in property dispositions. However, several SPACs (Charlton Aria, New America Acquisition I) show signs of distress with extended deadlines and director departures. NCR Voyix reported mixed Q2 results with revenue declining 21% YoY but recurring revenue growing, while maintaining full-year guidance. The overall sentiment is cautiously positive for active deal-making but with significant execution risks in the SPAC sector.

14 high priority 14 total filings
· daily

US Merger & Acquisition SEC Filings — August 04, 2026

The US M&A and takeover landscape during this period is characterized by a wave of SPAC activity, strategic corporate divestitures, and a landmark take-private transaction. Key themes include SPACs extending deadlines (Pyrophyte, Valuence) and financing mergers (Columbus, Calisa), alongside significant portfolio reshaping by operating companies (Resideo, Griffon, Digital Ally/Cycurion). The most material event is Electronic Arts' $210/share acquisition by a consortium led by PIF and Silver Lake, marking a major delisting and a shift in gaming industry ownership. Period-over-period data reveals a focus on deleveraging (Resideo's $900M debt repayment, Griffon's $181M cash infusion) and strategic pivots to higher-growth or core businesses (Digital Ally's exit from video solutions, Resideo's spin-off of ADI). Insider activity is limited, but sponsor participation in Calisa's subscription agreement signals confidence. Overall, the period reflects a mix of cautious extension strategies in the SPAC market and decisive value-unlocking actions by established companies.

14 high priority 14 total filings
· daily

US Merger & Acquisition SEC Filings — August 03, 2026

This USA M&A digest covers 16 filings, revealing a bifurcated market where strategic, well-capitalized acquirers (Brookfield, Teleflex, Esquire Financial) are executing transformative deals, while distressed situations (Sleep Number, Light Across) highlight the risks of forced sales and dilutive structures. Key period-over-period trends show a divergence in financial health: ONEOK reported strong operational growth (net income +13% YoY), whereas the Light Across acquisition target saw revenue collapse to zero and losses triple. Insider activity is limited but notable, with Bluerock's SPAC deal including insider PIPE investment from Yellow.ai founders, signaling confidence. Forward-looking guidance is a critical catalyst, with Teleflex set to provide updated 2026 guidance on August 6, and ONEOK raising its full-year outlook. Capital allocation is a central theme, with Teleflex planning a $1B buyback post-divestiture, contrasting with Sleep Number's zero recovery for equity holders. The most critical development is the completion of Brookfield's acquisition of Oaktree, creating a $365B credit platform, and Sleep Number's Chapter 11 asset sale, which serves as a cautionary tale for retail investors. A portfolio-level pattern is the rise of SPACs targeting AI and critical minerals (Bluerock/Yellow.ai, Newbridge/Startech, Freedom Metals), indicating sustained appetite for high-growth tech and resource deals despite market volatility.

16 high priority 16 total filings
· daily

US Merger & Acquisition SEC Filings — July 31, 2026

The USA M&A & Takeover Activity stream for July 31, 2026, reveals a market bifurcated between transformative, high-value deals and a wave of SPAC distress. Deluxe Corp's acquisition of Celero Commerce stands out as a high-conviction, accretive deal with clear synergy targets and a catalyst calendar, while several SPACs face existential risks: Agriculture & Natural Solutions Acquisition Corp is liquidating, Columbus Acquisition Corp is at risk of delisting, and Digital Asset Acquisition Corp postponed its shareholder vote. The period-over-period data is limited as most filings are event-driven 8-Ks without financial statements, but forward-looking statements and scheduled events provide actionable catalysts. Insider activity is absent across all filings, a notable gap that limits conviction signals. Capital allocation trends show a mix of SPAC IPOs raising $291 million in fresh capital versus liquidation and redemption events. The overall theme is one of selective opportunity in high-quality deals and caution in the SPAC space, where time is running out for many blank-check companies.

16 high priority 16 total filings
· daily

US Merger & Acquisition SEC Filings — July 30, 2026

The July 30, 2026 M&A digest reveals a bifurcated SPAC market: two newly-formed SPACs (B&R Technology, Lakeshore III) successfully raised capital and amended charters to pursue targets, while two existing SPACs (Keen Vision, DT Cloud Star) face imminent delisting for failing to complete business combinations, signaling a harsh penalty for prolonged deal inactivity. In the operational M&A space, two high-value transactions closed—Etsy’s $1.4B sale of Depop to eBay and Avanos Medical’s $1.27B take-private by AIP—both generating significant cash proceeds for the sellers. AiRWA’s $50M acquisition of Hong Kong Best Life introduces a unique crypto-based payment structure (USDT) and contingent earn-outs, while Iron Horse Acquisition II’s target, Electra Vehicles, secured a marquee client win (Propel Industries) for its battery AI platform. The overall period shows no material revenue or margin trends from these filings, as most are event-driven 8-Ks, but the insider activity and forward-looking data point to a clear catalyst calendar around shareholder votes and SEC reviews for pending deals.

12 high priority 12 total filings
· daily

US Merger & Acquisition SEC Filings — July 29, 2026

The July 29, 2026, US M&A stream reveals a bifurcated SPAC market: high-quality, well-capitalized deals (Westin/FCHS, Processa/Vidya) are proceeding, while others face massive shareholder redemptions (Inflection Point/Air Water at 24.7M shares, D. Boral/Exascale at 95.95% of public shares), signaling acute investor skepticism toward blank-check vehicles with uncertain targets. The Processa-Vidya acquisition stands out as a transformative, high-conviction biotech deal backed by a $200M PIPE, though existing shareholders face extreme dilution to ~0.9% ownership. On the capital formation side, Catalyst Acquisition Corp. successfully priced a $200M IPO targeting media/gaming, while Rising Dragon issued a small extension note to avoid liquidation. Period-over-period comparisons are limited in these event-driven filings, but the aggregate redemption data (two SPACs seeing >95% public exit) points to a systemic trust crisis in the SPAC structure. The lone non-SPAC deal, Medalist Diversified REIT's $5.8M property acquisition, represents a small, conservative real estate investment with no debt. Overall, the stream signals that only deals with strong strategic rationale and committed PIPE financing are likely to close, while weak SPACs face a 'show me the money' moment from public shareholders.

11 high priority 11 total filings
· daily

US Merger & Acquisition SEC Filings — July 28, 2026

The July 28, 2026 M&A landscape is dominated by SPAC activity (5 of 11 filings) and transformative healthcare/energy transactions. The most material event is the Yarrow-VYNE merger, a $200M-backed biotech roll-up with a mixed outlook due to severe dilution for legacy shareholders. In the energy sector, T1 Energy's $135M patent acquisition from Evervolt strengthens its vertical integration but carries acute financing risk with $133M due by October. The student housing sector shows strong fundamentals with Core University Living's $303.5M portfolio acquisition 99.4% pre-leased. The Cross Country Healthcare privatization by Knox Lane marks a significant healthcare staffing exit from public markets. A key period-over-period trend is the continued use of SPACs as a capital-raising vehicle, with $315M in new SPAC IPOs this week alone. Insider activity is minimal, but the VYNE special dividend ($17.3M) and deferred compensation structures at Charlton Aria signal careful capital management. The EchoStar $2.4B Wireless Creditor Trust represents a unique regulatory-driven M&A structure tied to FCC approvals.

11 high priority 11 total filings
· daily

US Merger & Acquisition SEC Filings — July 27, 2026

The July 27, 2026 M&A landscape is dominated by two significant completed acquisitions (Lattice Semiconductor/AMI and Novanta/Riverpoint Medical) that are expected to be immediately accretive to margins and earnings, signaling strong strategic execution in the semiconductor and medtech sectors. However, the SPAC market continues to show severe distress: Future Vision II Acquisition Corp. faces a massive 65% public share redemption despite overwhelming shareholder approval, while International Media Acquisition Corp. is burning through its final permitted extensions with no target in sight. A new cross-border deal from AiRWA Inc. introduces diversification but carries execution risk, and Translational Development Acquisition Corp. is still awaiting SEC effectiveness for its combination with ProLogium. Period-over-period trends from the enriched data reveal a clear bifurcation: operating companies are delivering accretive, value-creating M&A, while blank-check companies are struggling with redemptions, deadline pressures, and regulatory delays. Insider activity is absent across these filings, but forward-looking guidance from Lattice and Novanta points to strong revenue and earnings catalysts in early August.

7 high priority 7 total filings
· daily

US Merger & Acquisition SEC Filings — July 24, 2026

The July 24, 2026, M&A digest reveals a bifurcated market: large-cap strategic acquisitions (Berkshire Hathaway/Taylor Morrison) and SPAC-driven deals (Perceptive/Freenome) dominate headline materiality, while a wave of early-stage SPACs (AMR Resources, Range Capital) signal continued appetite for mineral resources and tactical targets. Period-over-period comparisons from the enriched data show a clear trend of cash-rich acquirers deploying capital into high-growth but cash-burning assets (Freenome's $1.45B accumulated deficit) and established homebuilding platforms (Taylor Morrison's 23,000 closings). Insider activity is muted across the SPAC cohort, but the Freenome PIPE ($240M) and Roche convertible note conversion indicate strong institutional conviction. A key outlier is KULR Technology, which sold 30% of its bitcoin holdings to deleverage, a defensive capital allocation move that contrasts with the broader M&A spending spree. The most critical development is the Taylor Morrison acquisition at a 10/10 materiality, which reshapes the US homebuilding landscape and signals Berkshire's aggressive push into vertically integrated housing.

7 high priority 7 total filings
· daily

US Merger & Acquisition SEC Filings — July 23, 2026

The July 23, 2026 filings reveal a bifurcated US M&A landscape: SPAC activity remains robust with two new IPOs (B&R Technology Merger Corp. raising $325M and Southern Cross Acquisition I Corp. raising $100M) and three SPACs extending deadlines (Cayson, Four Leaf, and Bleichroeder's Pasqal deal progressing), signaling sustained appetite for blank-check vehicles despite market volatility. However, the most actionable intelligence comes from operating companies: Gentherm posted record revenue ($416.2M, +11% YoY) but experienced margin compression (-70 bps) and a dramatic cash flow decline (from $31.7M to $2.3M), while raising guidance and announcing a $400M buyback—a mixed signal. Tharimmune's divestiture of Gravitas Life Sciences for a $3.5M promissory note improves its loss profile (pro forma net loss improving from -$35.9M to -$25.8M for FY2025) but leaves it with a $113.7M deferred tax liability and ongoing digital asset losses. XMax's indirect investment in Figure AI via a fund structure (48% interest for $8M) represents a novel SPV approach to accessing high-growth private AI. Portfolio-level trends show SPACs dominating volume (6 of 10 filings) but operating companies providing the most material financial insights, with period-over-period comparisons highlighting revenue growth offset by margin and cash flow deterioration.

10 high priority 10 total filings
· daily

US Merger & Acquisition SEC Filings — July 22, 2026

The July 22, 2026 M&A digest captures a bifurcated market: large-scale, accretive consolidations in real estate and consumer staples, alongside SPACs racing against the clock. The most material developments are the completion of Columbia Financial's acquisition of Northfield Bancorp (NFBK) and Public Storage's transformative deal for National Storage Affiliates Trust (NSA), which adds over 1,000 properties and immediate FFO accretion. Vita Coco's $175M acquisition of Copra signals strategic bolt-on M&A in premium beverage, while Nth Cycle's de-SPAC with Kensington Capital ($585M enterprise value) highlights appetite for critical minerals. However, two of three tracked SPACs (Black Hawk, Hudson) have extended their deadlines for the second time, indicating persistent deal-finding difficulties. Insider and financial data are sparse across these filings, limiting conviction signals. Key forward-looking catalysts include Nth Cycle's Q4 2026 de-SPAC close and Vita Coco's 2029 earnout, while the wave of SPAC extensions creates a risk of liquidations if deadlines are not met.

11 high priority 11 total filings
· daily

US Merger & Acquisition SEC Filings — July 21, 2026

The 18 filings reveal a bifurcated M&A landscape: SPAC activity is surging with three new IPOs (Samos Energy, Jones Ventures, AMR Resources) totaling $680 million in gross proceeds, alongside active deal financing (Aeon, Horizon Space) and advisory engagements (T-REX). However, this is tempered by notable failures—FACT II terminated its $175 million aerospace deal, and Vicarious Surgical is liquidating with zero expected recovery for stockholders. Operating company M&A shows mixed signals: Starco Brands' accretive acquisition of Custom Bakehouse ($20M revenue add) contrasts with Innovative Solutions' 1.5x revenue purchase of Aydin Displays, while Northpointe Bancshares' organic growth (MPP portfolio +36% YoY) is offset by margin compression (-11 bps YoY). Insider activity is sparse but negative, with Vicarious Surgical's entire board resigning and Flag Ship's auditor change flagged by material weaknesses. The overarching theme is capital rotation: SPACs are raising record sums but facing execution risk, while private equity take-privates (KORE Group) and targeted acquisitions signal selective value creation. No period-over-period comparisons were available for most filings, limiting trend analysis, but the data highlights a market favoring disciplined buyers over speculative SPACs.

18 high priority 18 total filings
· daily

US Merger & Acquisition SEC Filings — July 20, 2026

The July 20, 2026 M&A landscape is dominated by SPAC turbulence and precious metals consolidation. Two SPACs (Compass Digital, DT Cloud Star) face imminent dissolution or delisting due to failed business combinations and regulatory non-compliance, while Drugs Made In America navigates a complex three-party merger with massive shareholder redemptions. In precious metals, Gold Resource Corp's acquisition by Goldgroup Mining creates a combined entity with diversified Mexican and US assets, signaling sector consolidation. Aterian's asset sale and CVR issuance represents a distressed restructuring, while Aptorum Group's merger with DiamiR and reverse split aims for a Nasdaq fresh start. Mawson Infrastructure's JV acquisition of a Texas power site for AI/HPC use highlights the growing convergence of energy and digital infrastructure. Insider activity is sparse but notable, with Oxley Bridge's board resignation and Compass Digital's unanimous shareholder vote for wind-up indicating management alignment with dissolution. The period-over-period data reveals no revenue or margin trends as most filings are event-driven 8-Ks, but capital allocation patterns show a clear preference for cash preservation and trust account redemptions over growth investment.

9 high priority 9 total filings
· daily

US Merger & Acquisition SEC Filings — July 17, 2026

The July 17, 2026 US M&A digest reveals a bifurcated SPAC market: new issuance remains robust with two IPOs totaling $425M (Freedom Metals, Mercator Acquisition), while existing vehicles show mixed progress—one deal amendment (Inflection Point/GOWell), one termination with a pivot (Four Leaf/Data443), and one completed merger (Jet.AI/flyExclusive). Outside the SPAC space, two significant asset transactions closed: Braemar Hotels sold three properties for $432.7M (netting a $158.2M non-recurring gain), and Sadot Group acquired TradeIQ software IP for $6M. The most dilutive event is Jasper Therapeutics' acquisition of Kira Pharmaceuticals, where existing Jasper shareholders will own just 6.68% of the combined entity post-$132M PIPE. A notable period-over-period trend is the absence of revenue growth data in most filings, as SPACs and pre-revenue biotechs dominate. Insider activity is limited to a single director resignation (Activate Energy), providing no bullish conviction signals. Forward-looking data points to key catalysts: Jasper's pipeline milestones through 2028, Jet.AI's 90-day post-closing adjustment, and the Four Leaf/Data443 deal timeline.

12 high priority 12 total filings
· daily

US Merger & Acquisition SEC Filings — July 16, 2026

Today's M&A digest reveals a bifurcated US deal landscape: large-cap strategic consolidation (Baker Hughes/Chart Industries) versus distressed restructurings and SPAC extensions. The $4.3B Baker Hughes-Chart merger closed, creating a new industrial gas/cryogenics segment with $325M in targeted cost synergies, signaling confidence in energy transition and data center demand. Conversely, SpringBig's distressed asset transfer to lenders and Mainz Biomed's mixed-progress facility acquisition highlight execution risks in smaller-cap deals. Plum Acquisition Corp. IV's extension to July 2027 underscores ongoing SPAC challenges in finding viable targets. Catalyst Pharmaceuticals' post-merger charter amendments suggest a completed but undisclosed transaction. Key period-over-period trends are limited as most filings lack historical financials, but the Baker Hughes deal's 1.0-1.5x net leverage target within 24 months indicates disciplined balance sheet management post-acquisition. The overarching theme is a 'haves vs. have-nots' M&A environment where well-capitalized acquirers pursue transformative deals while distressed entities seek lifelines.

6 high priority 6 total filings
· daily

US Merger & Acquisition SEC Filings — July 15, 2026

The USA M&A & Takeover Activity stream for July 15, 2026, reveals a bifurcated SPAC market: two struggling shells (Ribbon Acquisition Corp., PHP Ventures) are burning cash on extensions, while a new entrant (Samos Energy) and a sponsor-backed vehicle (Yorkville Acquisition Corp.) signal renewed appetite for energy-focused and structured deals. The most material event is Glucotrack's reverse merger with Lōkahi Therapeutics, a high-conviction transaction where Lōkahi will control ~90% of the combined entity, supported by a private placement. Constellation Acquisition Corp I is advancing its HiTech Minerals merger with a scheduled investor event, but lacks financial updates. Nuvalent's post-acquisition filing indicates a completed deal but offers no financial terms, limiting actionable insight. Period-over-period data is sparse across filings, but insider activity (sponsor note conversion) and capital allocation (trust extensions, IPO pricing) provide key signals. The overall theme is a 'survival of the fittest' SPAC environment, with energy and biotech/medtech emerging as preferred sectors.

7 high priority 7 total filings